Related Experiment Video
Updated: Jun 26, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Tenofovir-associated nephrotoxicity in two HIV-infected adolescent males
Sarah M Wood1, Samir S Shah, Andrew P Steenhoff
1Division of Special Immunology, Children's Hospital of Philadelphia , Philadelphia, Pennsylvania 19104, USA.
Abstract:
We report two cases of tenofovir (TDF)-associated nephrotoxicity in perinatally HIV-infected adolescents. The first case, a 16-year-old African American male with an absolute CD4+ cell count of 314 cells/mm(3), presented with an abrupt rise in serum creatinine leading to irreversible renal failure while on TDF-containing highly active antiretroviral therapy (HAART). While the patient had evidence of underlying kidney disease, the timing of his renal failure indicates that TDF played a central role. The second case, a 16-year-old African-American male with an absolute CD4+ cell count of 895 cells/mm3, presented with rickets and hypophosphatemia while receiving TDF-based HAART. To our knowledge, these cases represent the first reports of TDF-associated irreversible renal failure and rickets in pediatric patients. We believe these cases highlight important and potentially irreversible side effects of this agent and emphasize the need for further studies of the renal safety of TDF in pediatric patients.
More Related Videos
Related Concept Videos
Antiviral Nucleoside Inhibitors
Retroviruses
Retrovirus Life Cycles
Pharmacokinetics in Pediatric Patients: Drug Excretion
Subviral Agents
Drug Toxicity: Risk factors

